Ginkgo Bioworks Holdings, Inc.

Healthcare

NYSE:DNA · New York Stock Exchange

Market Cap $575.18M Beta 1.80 P/E (TTM) -1.7

$9.17 +3.04%

+$0.26 today

52W Low $5.37High $17.58

Vol 1.54M · Avg 1.24M

EPS (TTM) -$5.11Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+7.50%

Period High

$16.14

Period Low

$5.48

Latest

$9.17

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.54B

ArriVent BioPharma, Inc. Common Stock

NASDAQ:AVBP

$1.48B

Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

$1.40B

MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

$1.37B

MeiraGTx Holdings plc

NASDAQ:MGTX

$1.03B

Replimune Group, Inc.

NASDAQ:REPL

$838.89M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$730.56M

Astria Therapeutics, Inc.

ATXS

$718.13M

Valneva SE

NASDAQ:VALN

$508.25M

Arvinas, Inc.

NASDAQ:ARVN

$488.07M

What is the latest DNA filing?

The latest filing shown is 4 dated Jun 15, 2026.

How many recent filings does DNA have?

Intrinsic Alpha currently shows 20 recent filings for DNA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.